Colgate-Palmolive COO sells 10,000 shares at $92

Q: What insider transaction did CL report for Panagiotis Tsourapas on August 24, 2026?

CL reported that officer Panagiotis Tsourapas indirectly sold 10,000 shares of common stock on August 24, 2026 in a transaction coded "S", indicating a sale in the open market or a private transaction.

Q: At what price did Panagiotis Tsourapas sell Colgate-Palmolive (CL) shares?

The filing shows a weighted average price of $92.0477 per share, with the 10,000 shares sold in multiple transactions at prices ranging from $92.00 to $92.12, inclusive.

Q: How many Colgate-Palmolive (CL) shares are held for Panagiotis Tsourapas in the company’s 401(k) plan?

The filing lists an additional holding of 4,619 shares of CL common stock held indirectly for Panagiotis Tsourapas by the issuer's 401(k) Plan Trustee.

Q: Was the Colgate-Palmolive (CL) insider sale under a Rule 10b5-1 trading plan?

The document-level Rule 10b5-1 checkbox is not checked (aff_10b5_one is false), and the footnotes do not state that the sale was made under a Rule 10b5-1 trading plan.

COLGATE PALMOLIVE CO (CL) reported that officer Panagiotis Tsourapas, COO, CD, EMEA, APac, Skin, indirectly sold 10,000 shares of common stock on August 24, 2026 in a sale coded "S".

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

COLGATE PALMOLIVE CO (CL) reported that officer Panagiotis Tsourapas, COO, CD, EMEA, APac, Skin, indirectly sold 10,000 shares of common stock on August 24, 2026 in a sale coded "S". The weighted average sale price was $92.0477 per share, with individual trades executed between $92.00 and $92.12 per share. After this transaction, an associated trust held 64,901 shares, which includes 12,661 shares that had previously been reported as directly beneficially owned. Separate holding entries show Tsourapas directly holding 9,074 shares and indirectly holding 4,619 shares through the issuer's 401(k) plan trustee.

Insider Trade Summary

Net Seller: 10,000 shares

Net Sell 3 txns

Insider Tsourapas Panagiotis

Role COO, CD, EMEA, APac, Skin

Sold 10,000 shs ($920K)

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F1, F2}	10,000	$92.0477	$920K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 64,901 shares (Indirect, By Trust); Common Stock — 9,074 shares (Direct); Common Stock — 4,619 shares (Indirect, By Issuer's 401(k) Plan Trustee)

Footnotes (2)

F1. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $92.00 to $92.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2. This amount includes 12,661 shares that were previously reported as directly beneficially owned.

Key Figures

Shares sold: 10,000 shares of Common Stock Weighted average sale price: $92.0477 per share Indirect trust holdings after transaction: 64,901 shares +3 more

6 metrics

Shares sold 10,000 shares of Common Stock Indirect sale by trust on August 24, 2026

Weighted average sale price $92.0477 per share Common Stock sale on August 24, 2026; trades between $92.00 and $92.12

Indirect trust holdings after transaction 64,901 shares Common Stock indirectly held by trust following the sale

Previously direct shares now included in trust amount 12,661 shares Now counted within the 64,901 indirect trust shares

Direct holdings after transaction 9,074 shares Common Stock directly held by Panagiotis Tsourapas

401(k) plan holdings 4,619 shares Common Stock held indirectly by issuer's 401(k) Plan Trustee

Key Terms

weighted average price, beneficially owned, 401(k) Plan Trustee, indirect ownership

4 terms

weighted average price financial

"Weighted average price, as these shares were sold in multiple transactions"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

beneficially owned financial

"This amount includes 12,661 shares that were previously reported as directly beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

401(k) Plan Trustee financial

"By Issuer's 401(k) Plan Trustee"

indirect ownership financial

"total_shares_following_transaction 64901.0000, direct_or_indirect I"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CL report for Panagiotis Tsourapas on August 24, 2026?

CL reported that officer Panagiotis Tsourapas indirectly sold 10,000 shares of common stock on August 24, 2026 in a transaction coded "S", indicating a sale in the open market or a private transaction.

At what price did Panagiotis Tsourapas sell Colgate-Palmolive (CL) shares?

The filing shows a weighted average price of $92.0477 per share, with the 10,000 shares sold in multiple transactions at prices ranging from $92.00 to $92.12, inclusive.

How many Colgate-Palmolive (CL) shares does the trust associated with Panagiotis Tsourapas hold after the sale?

After the reported sale, the trust associated with Panagiotis Tsourapas held 64,901 shares of CL common stock indirectly. This amount includes 12,661 shares that were previously reported as directly beneficially owned.

What are Panagiotis Tsourapas’s direct holdings of Colgate-Palmolive (CL) stock after the reported transactions?

A holding entry shows that after the reported transactions, Panagiotis Tsourapas directly held 9,074 shares of Colgate-Palmolive common stock.

How many Colgate-Palmolive (CL) shares are held for Panagiotis Tsourapas in the company’s 401(k) plan?

The filing lists an additional holding of 4,619 shares of CL common stock held indirectly for Panagiotis Tsourapas by the issuer's 401(k) Plan Trustee.

Was the Colgate-Palmolive (CL) insider sale under a Rule 10b5-1 trading plan?

The document-level Rule 10b5-1 checkbox is not checked (aff_10b5_one is false), and the footnotes do not state that the sale was made under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/26/2026 - 04:47 PM EDT Accepted by SEC EDGAR 08/26/2026 - 04:47 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tsourapas Panagiotis

(Last)

(First)

(Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK

10022

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	COO, CD, EMEA, APac, Skin

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/24/2026		S		10,000	D	$92.0477⁽¹⁾	64,901⁽²⁾	I	By Trust
Common Stock								9,074	D
Common Stock								4,619	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $92.00 to $92.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. This amount includes 12,661 shares that were previously reported as directly beneficially owned.

	/s/ Kristine Hutchinson, Attorney-in-Fact	08/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR